Moreover, recent evidence suggested that elevated ITGBL1 predicts adverse clinical outcomes in GC and might implicate the invasion and metastasis of GC cells by inducing epithelial-mesenchymal transition (Li R. et al., 2017). This evidence concerns the gene ITGBL1 and gastric cancer.